Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide

Applied Microbiology and Biotechnology

Volumn 92, Issue 6, 2011, Pages 1151-1160

  Kabir, M Enamul ^a,b   Karim, Nurul ^a,c   Krishnaswamy, Senthilkumar ^a   Selvakumar, Dakshnamurthy ^a,d   Miyamoto, Masahiko ^a   Furuichi, Yasuhiro ^e   Komiyama, Tadazumi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GeneCare Research Institute Co Ltd   (Japan)

Author keywords

1; 3 glucan; Antifungal peptides; Complementarity determining regions; HM 1 yeast killer toxin; Recombinant anti idiotypic antibody

Indexed keywords

3-GLUCAN; ANTI-FUNGAL; COMPLEMENTARITY DETERMINING REGIONS; HM-1 YEAST KILLER TOXIN; RECOMBINANT ANTI-IDIOTYPIC ANTIBODY;

BINDING ENERGY; CANDIDA; ECOLOGY; FUNGICIDES; PEPTIDES; SURFACE PLASMON RESONANCE; TOXIC MATERIALS; YEAST;

ANTIBODIES;

ANTIIDIOTYPIC ANTIBODY; BETA GLUCAN; FUNGICIDE; LAMINARAN; POLYPEPTIDE ANTIBIOTIC AGENT; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; YEAST KILLER FACTOR;

ANTIBODY; ANTIMICROBIAL ACTIVITY; FUNGICIDE; IMMUNOASSAY; INHIBITOR; PEPTIDE; RECOMBINATION; TOXIN; YEAST;

ANTIFUNGAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL WALL; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; DRUG POTENCY; FUNGAL CELL; FUNGAL STRAIN; FUNGUS GROWTH; GROWTH INHIBITION; IC 50; IN VITRO STUDY; NONHUMAN; PROTEIN BINDING; SACCHAROMYCES CEREVISIAE; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANTIBODIES, ANTI-IDIOTYPIC; ANTIFUNGAL AGENTS; FUNGI; KILLER FACTORS, YEAST; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDES; SINGLE-CHAIN ANTIBODIES;

CANDIDA; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 82455208963     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3412-2     Document Type: Article

References (36)

1. E Eilat M Dayan H Zinger E Mozes 2001 The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus Proc Natl Acad Sci USA 98 1148 1153 10.1073/pnas.98.3.1148 1:CAS:528:DC%2BD3MXht1Smtro%3D (Pubitemid 32121201)
2. T Ganz RI Lehrer 1999 Antibiotic peptides from higher eukaryotes: biology and applications Mol Med Today 5 292 297 10.1016/S1357-4310(99)01490-2 1:CAS:528:DyaK1MXkvFGjurw%3D (Pubitemid 29302676)
3. AH Groll TJ Walsh 2001 Uncommon opportunistic fungi: new nosocomial threats Clin Microbiol Infect 7 8 24 10.1111/j.1469-0691.2001.tb00005.x 1:CAS:528:DC%2BD3MXkt1OisbY%3D
4. LC Gruen AA Kortt E Nice 1993 Determination of relative binding affinity of influenza virus N9 sialidases with the Fab fragment of monoclonal antibody NC41 using biosensor technology Eur J Biochem 217 319 325 10.1111/j.1432-1033. 1993.tb18249.x 1:CAS:528:DyaK3sXmtVWns7s%3D (Pubitemid 23305302)
5. F Heitz MC Morris G Divita 2009 Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br J Pharmacol 157 195 206 10.1111/j.1476-5381.2009.00057.x 1:CAS:528:DC%2BD1MXmsFWju7k%3D
6. RG Holzheimer H Dralle 2002 Management of mycoses in surgical patients-review of the literature Eur J Med Res 7 200 226
7. L Hovi UM Saarinen-Pihkala K Vettenranta H Saxen 2000 Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years Bone Marrow Transplant 26 999 1004 10.1038/sj.bmt.1702654 1:STN:280:DC%2BD3M7kt1Gltg%3D%3D
8. R Hussain N Courtenay-Luck G Siligardi 1996 Structure-function correlation and biostability of antibody CDR-derived peptides as tumor imaging agents Biomed Pept Proteins Nucleic Acids 2 67 70 1:CAS:528:DyaK1cXjt1Shtrg%3D
9. EA Kabat 1988 Antibody complementarity and antibody structure J Immunol 141 25 36
10. ME Kabir S Krishnaswamy M Miyamoto Y Furuichi T Komiyama 2009 An improved phage-display panning method to produce an HM-1 killer toxin anti-idotypic antibody BMC Biotechnol 9 99 10.1186/1472-6750-9-99
11. S Kasahara S Ben Inoue T Mio T Yamada T Nakajima E Ichishima Y Furuichi H Yamada 1994 Involvement of cell wall β-glucan in the action of HM-1 killer toxin FEBS Lett 1 27 32 10.1016/0014-5793(94)00575-3 (Pubitemid 24223027)
12. T Komiyama T Ohta H Urakami Y Shiratori T Takasuka M Satoh T Watanabe Y Furuichi 1996 Pore formation on proliferating yeast Saccharomyces cerevisiae cell buds by HM-1 killer toxin J Biochem 4 731 736 (Pubitemid 26135149)
13. S Krishnaswamy ME Kabir M Miyamoto Y Furuichi T Komiyama 2009 Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution Anal Biochem 395 16 24 10.1016/j.ab.2009.08.003 1:CAS:528:DC%2BD1MXhtFKnsLfJ
14. PW Latham 1999 Therapeutic peptides revisited Nat Biotechnol 17 755 757 10.1038/11686 1:CAS:528:DyaK1MXmtFaiuro%3D (Pubitemid 29365101)
15. M Levi M Sällberg U Rudén D Herlyn H Maruyama H Wigzell J Marks B Wahren 1993 A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro Proc Natl Acad Sci USA 90 4374 4378 10.1073/pnas.90.10.4374 1:CAS:528: DyaK3sXltFGiur0%3D (Pubitemid 23148906)
16. W Magliani S Conti F de Bernardis M Gerloni D Bertolotti P Mozzoni A Cassone L Polonelli 1997 Therapeutic potential of anti-idiotypic single chain antibodies with yeast killer toxin activity Nat Biotechnol 15 2 155 158 10.1038/nbt0297-155 1:CAS:528:DyaK2sXptFaqsg%3D%3D (Pubitemid 27081781)
17. Majumdar S, Siahaan TJ (2010) Peptide-mediated targeted drug delivery. Med Res Rev Sep 2.
18. DK Malik S Baboota A Ahuja S Hasan J Ali 2007 Recent advances in protein and peptide drug delivery systems Curr Drug Deliv 4 141 151 10.2174/ 156720107780362339 1:CAS:528:DC%2BD2sXjtlWhtr4%3D (Pubitemid 46557490)
19. PL Myskowski MH White R Ahkami 1997 Fungal disease in the immunocompromised host Dermatol Clin 15 295 305 10.1016/S0733-8635(05)70437-X 1:STN:280:DyaK2s3ltlWqtw%3D%3D (Pubitemid 27157174)
20. L Polonelli W Magliani S Conti L Bracci L Lozzi P Neri D Adriani F De Bernardis A Cassone 2003 Therapeutic activity of an engineered synthetic killer anti-idiotypic antibody fragment against experimental mucosal and systemic candidiasis Infect Immun 71 11 6205 6212 10.1128/IAI.71.11.6205-6212.2003 1:CAS:528:DC%2BD3sXoslegu7k%3D (Pubitemid 37337676)
21. L Polonelli J Pontón N Elguezabal MD Moragues C Casoli E Pilotti P Ronzi AS Dobroff EG Rodrigues MA Juliano DL Maffei W Magliani S Conti LR Travassos 2008 Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities PLoS One 3 6 e2371 10.1371/journal.pone.0002371
22. A Safdar V Chaturvedi EW Cross S Park EM Bernard D Armstrong DS Perlin 2001 Prospective study of Candida species in patients at a comprehensive cancer center Antimicrob Agents Chemother 45 2129 2133 10.1128/AAC.45.7.2129-2133.2001 1:CAS:528:DC%2BD3MXks1GksLk%3D (Pubitemid 32591711)
23. HU Saragovi D Fitzpatrick A Raktabutr H Nakanishi M Kahn MI Greene 1991 Design and synthesis of a mimetic from an antibody complementarity-determining region Science 253 792 795 10.1126/science.1876837 1:CAS:528:DyaK3MXlvVWjsbw%3D (Pubitemid 21917219)
24. AK Sato M Viswanathan RB Kent CR Wood 2006 Therapeutic peptides: technological advances driving peptides into development Curr Opin Biotechnol 17 638 642 10.1016/j.copbio.2006.10.002 1:CAS:528:DC%2BD28Xht1eqs7zL (Pubitemid 44791908)
25. D Selvakumar M Miyamoto Y Furuichi T Komiyama 2006 Inhibition of Fungal β-1,3-0glucan synthase and cell growth by HM-1 Killer toxin single-chain anti-idiotypic antibodies Antimicrob Agents Chemother 50 3090 3097 10.1128/AAC.01435-05 1:CAS:528:DC%2BD28XpsFemsr0%3D (Pubitemid 44396416)
26. D Selvakumar N Karim M Miyamoto Y Furuichi T Komiyama 2006 Recombinant single-chain anti-idiotypic antibody: an effective fungal β-1,3-glucan synthase inhibitor Biol Pharm Bull 29 1848 1853 10.1248/bpb.29.1848 1:CAS:528:DC%2BD28XhtFCgtb7P (Pubitemid 44338406)
27. D Selvakumar M Miyamoto Y Furuichi T Komiyama 2006 Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies J Antibiot 59 73 79 10.1038/ja.2006.10 1:CAS:528:DC%2BD28XisVajt7c%3D
28. D Selvakumar QZ Zhang M Miyamoto Y Furuichi T Komiyama 2006 Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin J Biochem 139 399 406 10.1093/jb/mvj042 1:CAS:528:DC%2BD28XkslOgtbs%3D (Pubitemid 43667104)
29. MG Shepherd 1987 Cell envelope of Candida albicans Crit Rev Microbiol 15 7 25 10.3109/10408418709104445 1:STN:280:DyaL1c%2FotFKqtA%3D%3D
30. T Takasuka T Komiyama Y Furuichi T Watanabe 1995 Cell wall synthesis specific cytocidal effect of Hansenula mrakii toxin-1 on Saccharomyces cerevisiae Cell Mol Biol Res 41 575 581 1:CAS:528:DyaK28XitFShtrw%3D (Pubitemid 26124143)
31. LR Travassos LS Silva EG Rodrigues S Conti A Salati W Magloiani L Polonelli 2004 Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis J Antimicrob Chemother 54 956 958 10.1093/jac/dkh430 1:CAS:528:DC%2BD2cXhtVSru7vL (Pubitemid 39529994)
32. JR Wingard 1995 Importance of Candida species other than C. albicans as pathogens in oncology patients Clin Infect Dis 20 115 125 10.1093/clinids/20.1. 115 1:STN:280:DyaK2M3ksVOiuw%3D%3D
33. T Yamamoto M Imai K Tachibana M Mayumi 1986 Application of monoclonal antibodies to the isolation and characterization of a killer toxin secreted by Hansenula mrakii FEBS Lett 195 253 257 10.1016/0014-5793(86)80170-3 1:CAS:528:DyaL28XhtVClsbw%3D
34. T Yamamoto T Hiratani H Hirata M Imai H Yamaguchi 1986 Killer toxin from Hansenula mrakii selectively inhibits cell wall synthesis in a sensitive yeast FEBS Lett 197 50 54 10.1016/0014-5793(86)80296-4 1:CAS:528:DyaL28Xhs1ensLk%3D (Pubitemid 16037893)
35. T Yamamoto K Uchida T Hiratani T Miyazaki J Yagiu H Yamaguchi 1988 In vitro activity of the killer toxin from yeast Hansenula mrakii against yeasts and molds J Antibiot (Tokyo) 41 398 403 1:CAS:528:DyaL1cXkt1Sit7w%3D (Pubitemid 18096569)
36. D Zupanić-Krmek D Nemet 2004 Systemic fungal infections in immunocompromised patients Acta Med Croatica 58 251 261 (Pubitemid 40137519)